We know what it will take to eliminate TB. We know we need new and effective vaccines, including simpler and shorter TB treatments, ones that work against drug resistant TB and we know better diagnostic tests are needed. All our TB programs are focused on advancing these goals and we are making progress.
At KEMRI/CDC we are working in the hope of seeing a future without needless deaths from TB.
In 1979 the US Centers for Disease Control and Prevention (CDC) and the Kenya Medical Research Institute (KEMRI) established a partnership called the KEMRI/CDC Research and Public Health Collaboration to focus on malaria research. The collaboration has expanded its mission and staffing to become a comprehensive research platform with projects and studies located throughout Kenya. KEMRI/CDC’s work now includes research on HIV, TB, emerging infections, neglected tropical diseases and other public health issues.
The collaboration includes support for HIV prevention and care programs and a state-of-the-art health and demographic surveillance system (HDSS) and other population-based platforms to assess disease burden, disease outbreaks and health intervention impact in communities.
The KEMRI/CDC TB branch tackles tough TB problems by directly working with vulnerable families and communities.
Our professional relationships, high quality services, and expert staff form a foundation for innovation and collaboration serving to measure the TB burden in Kenya and helping to foster new and creative ways of combating the disease.
• Recent TB survey in Asembo and Gem successfully uncovered a high burden of undiagnosed TB suggesting efforts to find more of these cases is needed
• Creating lab and management expertise to conduct large clinical trials
• An on-going community partnership project to reduce the burden of TB in the community is showing success
• Became member of the tuberculosis clinical trials consortium, an international association working to find better TB treatment